Neutrophil migration in infection and wound repair: Going forward in reverse

Nature Reviews Immunology

Volumn 16, Issue 6, 2016, Pages 378-391

  De Oliveira, Sofia ^a   Rosowski, Emily E ^a   Huttenlocher, Anna ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHEMOATTRACTANT; CYTOSOLIC PHOSPHOLIPASE A2; HYDROGEN PEROXIDE; INTERLEUKIN 8; LIPID; RECEPTOR;

CELL DAMAGE; CELL EXPANSION; CELL FUNCTION; CELL MIGRATION; DAMAGE ASSOCIATED MOLECULAR PATTERNS; ENZYME ACTIVITY; EXTRAVASATION; INFECTION; INFLAMMATION; INTRACELLULAR SIGNALING; LEUKOCYTE ACTIVATION; MICROENVIRONMENT; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL DETECTION; TISSUE INJURY; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; VASCULARIZATION; WOUND HEALING; WOUND INFECTION; ZEBRA FISH; ANIMAL; DRUG EFFECTS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; HUMANS; INFECTION; INFLAMMATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84971280329     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2016.49     Document Type: Review

References (193)

1. Kolaczkowska E, & Kubes P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159-175 (2013).
2. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173-182 (2006).
3. Borregaard N. Neutrophils, from marrow to microbes. Immunity. 33, 657-670 (2010).
4. Caielli S, Banchereau J, & Pascual V. Neutrophils come of age in chronic inflammation. Curr. Opin. Immunol. 24, 671-677 (2012).
5. Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol. Rev. 186, 8-18 (2002).
6. Gambardella L, & Vermeren S. Molecular players in neutrophil chemotaxis-focus on PI3K and small GTPases. J. Leukoc. Biol. 94, 603-612 (2013).
7. Ng L. G, et al. Visualizing the neutrophil response to sterile tissue injury in mouse dermis reveals a three-phase cascade of events. J. Investigative Dermatol. 131, 2058-2068 (2011).
8. L?mermann T. In the eye of the neutrophil swarm-navigation signals that bring neutrophils together in inflamed and infected tissues. J. Leukoc. Biol. pii: jlb.1MR0915 403 (2015).
9. Nourshargh S, & Alon R. Leukocyte migration into inflamed tissues. Immunity. 41, 694-707 (2014).
10. Weninger W, Biro M, & Jain R. Leukocyte migration in the interstitial space of non-lymphoid organs. Nat. Rev. Immunol. 14, 232-246 (2014).
11. Futosi K, Fodor S, & M?sai A. Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int. Immunopharmacol. 17, 638-650 (2013).
12. Sun L, & Ye R. D. Role of G protein-coupled receptors in inflammation. Acta Pharmacol. Sin. 33, 342-350 (2012).
13. Viola A, & Luster A. D. Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 48, 171-197 (2008).
14. Pittman K, & Kubes P. Damage-Associated molecular patterns control neutrophil recruitment. J. Innate Immun. 5, 315-323 (2013).
15. Broggi A, & Granucci F. Microbe- And danger-induced inflammation. Mol. Immunol. 63, 127-133 (2015).
16. Vneeau E, Ceriotti C, & Bianchi M. E. DAMPs from Cell Death to New Life. Frontiers Immunol. 6, 422 (2015).
17. Cordeiro J. V. V, & Jacinto A. The role of transcription-independent damage signals in the initiation of epithelial wound healing. Nat. Rev. Mol. Cell Biol. 14, 249-262 (2013).
18. Niethammer P, Grabher C, Look A. T, & Mitchison T. J. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459 996-999 (2009).
19. Moreira S, Stramer B, Evans I, Wood W, & Martin P. Prioritization of competing damage and developmental signals by migrating macrophages in the Drosophila embryo. Curr. Biol. 20, 464-470 (2010).
20. Yoo S. K, Starnes T. W, Deng Q, & Huttenlocher A. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature. 480, 109-112 (2011).
21. Klyubin I. V, Kirpichnikova K. M, & Gamaley I. A. Hydrogen peroxide-induced chemotaxis of mouse peritoneal neutrophils. Eur. J. Cell Biol. 70, 347-351 (1996).
22. Kov?s M, et al. The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment. J. Exp. Med. 211, 1993-2011 (2014).
23. Baroja-Mazo A, Barber -Cremades M, & Pelegr?, P. The participation of plasma membrane hemichannels to purinergic signaling. Biochim. Biophys. Acta 1828, 79-93 (2013).
24. de Oliveira S, et al. ATP modulates acute inflammation in vivo through dual oxidase 1 derived H2O2 production and NF ?B activation. J. Immunol. 192, 5710-5719 (2014).
25. Elliott M. R, et al. Nucleotides released by apoptotic cells act as a find me signal to promote phagocytic clearance. Nature. 461, 282-286 (2009).
26. Chen Y, et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science. 314, 1792-1795 (2006).
27. Bao Y, et al. mTOR and differential activation of mitochondria orchestrate neutrophil chemotaxis. J. Cell Biol. 210, 1153-1164 (2015).
28. Kukulski F, et al. Extracellular ATP and P2 receptors are required for IL 8 to induce neutrophil migration. Cytokine. 46, 166-170 (2009).
29. Lecut C, et al. P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation. J. Immunol 183 2801-2809 (2009).
30. Zhang Q, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 464, 104-107 (2010).
31. Raoof M, Zhang Q, Itagaki K, & Hauser C. J. Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR 1. J. Trauma. 68, 1328 (2010).
32. Li L, et al. New development in studies of formyl-peptide receptors: critical roles in host defense. J. Leukoc. Biol. 99, 425-435 (2015).
33. McDonald B, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science. 330, 362-366 (2010).
34. Pase L, et al. Neutrophil-delivered myeloperoxidase dampens the hydrogen peroxide burst after tissue wounding in zebrafish. Curr. Biol. 22, 1818-1824 (2012).
35. Russo R. C, Garcia C. C, Teixeira M. M, & Amaral F. A. The CXCL8/IL 8 chemokine family and its receptors in inflammatory diseases. Expert Rev. Clin. Immunol. 10, 593-619 (2014).
36. Kobayashi Y. The role of chemokines in neutrophil biology. Frontiers Biosci. 13, 2400-2407 (2008).
37. Sai J, Raman D, Liu Y, Wikswo J, & Richmond A. Parallel phosphatidylinositol 3 kinase (PI3K)- dependent and Src-dependent pathways lead to CXCL8 mediated Rac2 activation and chemotaxis. J. Biol. Chem. 283, 26538-26547 (2008).
38. Neel N. F, et al. VASP is a CXCR2 interacting protein that regulates CXCR2 mediated polarization and chemotaxis. J. Cell Sci. 122, 1882-1894 (2009).
39. Lindley I, et al. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-Activating factor: biological equivalence between natural and recombinant neutrophil-Activating factor. Proc. Natl Acad. Sci. USA. 85, 9199-9203 (1988).
40. de Oliveira S, et al. Cxcl8 (IL 8) mediates neutrophil recruitment and behavior in the zebrafish inflammatory response. J. Immunol. 190, 4349-4359 (2013).
41. Deng Q, et al. Localized bacterial infection induces systemic activation of neutrophils through Cxcr2 signaling in zebrafish. J. Leukoc. Biol. 93, 761-769 (2013).
42. Sarris M, et al. Inflammatory chemokines direct and restrict leukocyte migration within live tissues as glycan-bound gradients. Curr. Biol. 22, 2375-2382 (2012).
43. Cacalano G, et al. Neutrophil and B cell expansion in mice that lack the murine IL 8 receptor homolog. Science. 265, 682-684 (1994).
44. Devalaraja R. M, et al. Delayed wound healing in CXCR2 knockout mice. J. Invest. Dermatol. 115, 234-244 (2000).
45. Monneau Y, Arenzana-Seisdedos F, & Lortat-Jacob H. The sweet spot: how GAGs help chemokines guide migrating cells. J. Leukoc. Biol. pii: jlb.3MR0915 440R (2015).
46. Middleton J, et al. Transcytosis and surface presentation of IL 8 by venular endothelial cells. Cell. 91, 385-395 (1997).
47. Powell W. S, Gravel S, MacLeod R. J, Mills E, & Hashefi M. Stimulation of human neutrophils by 5 oxo 6,8,11,14 eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor. J. Biol. Chem. 268, 9280-9286 (1993).
48. Øynebråten I, et al. Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol. J. Immunol. 175, 5358-5369 (2005).
49. Hol J, Wilhelmsen L, & Haraldsen G. The murine IL 8 homologues KC, MIP 2, and LIX are found in endothelial cytoplasmic granules but not in Weibel- Palade bodies. J. Leukoc. Biol. 87, 501-508 (2010).
50. Iyer S. S, et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl Acad. Sci. USA. 106, 20388-20393 (2009).
51. Enyedi B, Kala S, Nikolich-Zugich T, & Niethammer P. Tissue damage detection by osmotic surveillance. Nat. Cell Biol. 15, 1123-1130 (2013).
52. Sadik C. D, & Luster A. D. Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation. J. Leukoc. Biol. 91, 207-215 (2012).
53. Afonso P. V, et al. LTB4 is a signal-relay molecule during neutrophil chemotaxis. Dev. Cell. 22, 1079-1091 (2012).
54. Lämmermann T, et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature. 498, 371-375 (2013).
55. Wipke B. T, & Allen P. M. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167, 1601-1608 (2001).
56. Chen M, et al. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J. Exp. Med. 203, 837-842 (2006).
57. Hazeldine J, Hampson P, Opoku F. A, Foster M, & Lord J. M. N Formyl peptides drive mitochondrial damage associated molecular pattern induced neutrophil activation through ERK1/2 and P38 MAP kinase signalling pathways. Injury 46 975-984 (2015).
58. Chou R. C, et al. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity. 33, 266-278 (2010).
59. Van den Steen P. E, Proost P, Wuyts A, Van Damme J, & Opdenakker G. Neutrophil gelatinase B potentiates interleukin 8 tenfold by amino-Terminal processing, whereas it degrades CTAP-III, PF 4, and GRO-α and leaves RANTES and MCP 2 intact. Blood. 96, 2673-2681 (2000).
60. Tester A. M, et al. LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP 8 activity. PLoS ONE 2, e312. (2007).
61. Afonso P. V, McCann C. P, Kapnick S. M, & Parent C. A. Discoidin domain receptor 2 regulates neutrophil chemotaxis in 3D collagen matrices. Blood. 121, 1644-1650 (2013).
62. Soehnlein O, & Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10, 427-439 (2010).
63. Peters N. C, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science. 321, 970-974 (2008).
64. Kreisel D, et al. In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc. Natl Acad. Sci. USA. 107, 18073-18078 (2010).
65. Chtanova T, et al. Dynamics of neutrophil migration in lymph nodes during infection. Immunity. 29, 487-496 (2008).
66. Silva M. T. Bacteria-induced phagocyte secondary necrosis as a pathogenicity mechanism. J. Leukoc. Biol. 88, 885-896 (2010).
67. Gonzalez C. D, Ledo C, Giai C, Garófalo A, & Gómez M. I. The Sbi protein contributes to Staphylococcus aureus inflammatory response during systemic infection. PLoS ONE 10, e0131879 (2015).
68. Abtin A, et al. Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat. Immunol. 15, 45-53 (2014).
69. Spinner J. L, Hasenkrug A. M, Shannon J. G, Kobayashi S. D, & Hinnebusch B. J. Role of the Yersinia YopJ protein in suppressing interleukin 8 secretion by human polymorphonuclear leukocytes. Microbes Infect. 18, 21-29 (2016).
70. Palm N. W, & Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 227, 221-233 (2009).
71. Schiwon M, et al. Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium. Cell. 156, 456-468 (2014).
72. Sacramento L, et al. TLR9 signaling on dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection. Infect. Immun. 83, 4604-4616 (2015).
73. Abraham S. N, & John A. L. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10, 440-452 (2010).
74. Krishna S, & Miller L. S. Innate and adaptive immune responses against Staphylococcus aureus skin infections. Semin. Immunopathol. 34, 261-280 (2012).
75. Malaviya R, Ikeda T, Ross E, & Abraham S. N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature. 381, 77-80 (1996).
76. Huang C, et al. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J. Immunol. 160, 1910-1919 (1998).
77. Malaviya R, & Abraham S. N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukoc. Biol. 67, 841-846 (2000).
78. Miller L. S, et al. Inflammasome-mediated production of IL 1β is required for neutrophil recruitment against Staphylococcus aureus in vivo. J. Immunol. 179, 6933-6942 (2007).
79. Shimada T, et al. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL 1β secretion. Cell Host Microbe. 7, 38-49 (2010).
80. Miller L. S, et al. MyD88 mediates neutrophil recruitment initiated by IL 1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity. 24, 79-91 (2006).
81. Sun K, Salmon S. L, Lotz S. A, & Metzger D. W. Interleukin 12 promotes γ interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect. Immun. 75, 1196-1202 (2007).
82. Kabir S. The role of interleukin 17 in the Helicobacter pylori induced infection and immunity. Helicobacter. 16, 1-8 (2011).
83. Scapini P, & Cassatella M. A. Social networking of human neutrophils within the immune system. Blood. 124, 710-719 (2014).
84. Isailovic N, Daigo K, Mantovani A, & Selmi C. Interleukin 17 and innate immunity in infections and chronic inflammation. J. Autoimmun. 60, 1-11 (2015).
85. Rendon J. L, & Choudhry M. A. Th17 cells: critical mediators of host responses to burn injury and sepsis. J. Leukoc. Biol. 92, 529-538 (2012).
86. Mölne L, Verdrengh M, & Tarkowski A. Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect. Immun. 68, 6162-6167 (2000).
87. Ley K, Smith E, & Stark M. A. IL 17A producing neutrophil-regulatory Tn lymphocytes. Immunol. Res. 34, 229-242 (2006).
88. Xu S, & Cao X. Interleukin 17 and its expanding biological functions. Cell. Mol. Immunol. 7, 164-174 (2010).
89. Cho J. S, et al. IL 17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120, 1762-1773 (2010).
90. Liese J, Rooijakkers S. H, van Strijp J. A, Novick R. P, & Dustin M. L. Intravital two-photon microscopy of host-pathogen interactions in a mouse model of Staphylococcus aureus skin abscess formation. Cell. Microbiol. 15, 891-909 (2013).
91. Tan R. S, Ho B, Leung B. P, & Ding J. L. TLR cross-Talk confers specificity to innate immunity. Int. Rev. Immunol. 33, 443-453 (2014).
92. Deng Q, Harvie E. A, & Huttenlocher A. Distinct signalling mechanisms mediate neutrophil attraction to bacterial infection and tissue injury. Cell. Microbiol. 14, 517-528 (2012).
93. Yan B, et al. IL 1β and reactive oxygen species differentially regulate neutrophil directional migration and Basal random motility in a zebrafish injury-induced inflammation model. J. Immunol. 192, 5998-6008 (2014).
94. Hamza B, & Irimia D. Whole blood human neutrophil trafficking in a microfluidic model of infection and inflammation. Lab. Chip. 15, 2625-2633 (2015).
95. Liu Y, Chen G. Y. Y, & Zheng P. CD24 Siglec G/10 discriminates danger- from pathogen-Associated molecular patterns. Trends Immunol. 30, 557-561 (2009).
96. Chen G. Y. Y, Brown N. K, Zheng P, & Liu Y. Siglec G/10 in self-nonself discrimination of innate and adaptive immunity. Glycobiology. 24, 800-806 (2014).
97. Chen G. Y. Y, Tang J, Zheng P, & Liu Y. CD24 and Siglec 10 selectively repress tissue damage-induced immune responses. Science. 323, 1722-1725 (2009).
98. Kruger P, et al. Neutrophils: Between host defence, immune modulation, and tissue injury. PLoS Pathog. 11, e1004651 (2015).
99. Buckley C. D, Gilroy D. W, Serhan C. N, Stockinger B, & Tak P. P. The resolution of inflammation. Nat. Rev. Immunol. 13, 59-66 (2013).
100. Hughes J, et al. Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis. Am. J. Pathol. 150, 223-234 (1997).
101. Mathias J. R, et al. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J. Leukoc. Biol. 80, 1281-1288 (2006).
102. Yoo S. K, & Huttenlocher A. Spatiotemporal photolabeling of neutrophil trafficking during inflammation in live zebrafish. J. Leukoc. Biol. 89, 661-667 (2011).
103. Hall C, et al. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages. J. Leukoc. Biol. 85, 751-765 (2009).
104. Buckley C. D, et al. Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J. Leukoc. Biol. 79, 303-311 (2006).
105. Elks P. M, et al. Activation of hypoxia-inducible factor 1α (Hif 1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. Blood. 118, 712-722 (2011).
106. Ellett F, Elks P. M, Robertson A. L, Ogryzko N. V, & Renshaw S. A. Defining the phenotype of neutrophils following reverse migration in zebrafish. J. Leukoc. Biol. 98, 975-981(2015).
107. Robertson A. L, et al. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism. Sci. Transl Med. 6, 225ra29 (2014).
108. Tauzin S, Starnes T. W, Becker F. B, Lam P. Y. Y, & Huttenlocher A. Redox and Src family kinase signaling control leukocyte wound attraction and neutrophil reverse migration. J. Cell Biol. 207, 589-598 (2014).
109. Duffy D, et al. Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cells. Immunity. 37, 917-929 (2012).
110. Woodfin A, et al. The junctional adhesion molecule JAM C regulates polarized transendothelial migration of neutrophils in vivo. Nat. Immunol. 12, 761-769 (2011).
111. Hamza B, et al. Retrotaxis of human neutrophils during mechanical confinement inside microfluidic channels. Integr. Biol. 6, 175-183 (2014).
112. Vianello F, Olszak I. T, & Poznansky M. C. Fugetaxis: active movement of leukocytes away from a chemokinetic agent. J. Mol. Med. 83, 752-763 (2005).
113. Starnes T. W, & Huttenlocher A. Neutrophil reverse migration becomes transparent with zebrafish. Adv. Hematol. 2012, 398640 (2012).
114. Tharp W. G, et al. Neutrophil chemorepulsion in defined interleukin 8 gradients in vitro and in vivo. J. Leukoc. Biol. 79, 539-554 (2006).
115. Kuijpers T, & Lutter R. Inflammation and repeated infections in CGD: two sides of a coin. Cell. Mol. Life Sci. 69, 7-15 (2012).
116. Serhan C. N, Chiang N, Dalli J, & Levy B. D. Lipid mediators in the resolution of inflammation. Cold Spring Harb. Perspect. Biol.7, a016311 (2015).
117. Buckley C. D, Gilroy D. W, & Serhan C. N. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 40, 315-327 (2014).
118. Serhan C. N, & Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr. Opin. Pharm. 13, 632-640 (2013).
119. Colom B, et al. Leukotriene B4 neutrophil elastase axis drives neutrophil reverse transendothelial cell migration in vivo. Immunity. 42, 1075-1086 (2015).
120. Beyrau M, Bodkin J. V, & Nourshargh S. Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol. 2, 120134 (2012).
121. Holmes G. R, et al. Drift-diffusion analysis of neutrophil migration during inflammation resolution in a zebrafish model. Adv. Hematol. 2012, 792163 (2012).
122. Holmes G. R, et al. Repelled from the wound, or randomly dispersed? Reverse migration behaviour of neutrophils characterized by dynamic modelling. J. R. Soc, Interface. 9, 3229-3239 (2012).
123. Sadik C. D, Kim N. D, & Luster A. D. Neutrophils cascading their way to inflammation. Trends Immunol. 32, 452-460 (2011).
124. Tsukamoto T, Chanthaphavong R. S, & Pape H. C. C. Current theories on the pathophysiology of multiple organ failure after trauma. Injury. 41, 21-26 (2010).
125. Wu D, et al. Reverse-migrated neutrophils regulated by JAM C are involved in acute pancreatitis-Associated lung injury. Sci. Rep. 6, 20545 (2016).
126. Hampton H. R, Bailey J, Tomura M, Brink R, & Chtanova T. Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes. Nat. Commun. 6, 7139 (2015).
127. Abadie V, et al. Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood. 106, 1843-1850 (2005).
128. Maletto B. A, et al. Presence of neutrophil-bearing antigen in lymphoid organs of immune mice. Blood. 108, 3094-3102 (2006).
129. Wright H. L, Moots R. J, & Edwards S. W. The multifactorial role of neutrophils in rheumatoid arthritis. Nat. Rev. Rheumatol. 10, 593-601 (2014).
130. Cantin A. M. M, Hartl D, Konstan M. W, & Chmiel J. F. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy. J. Cyst. Fibros. 14, 419-430 (2015).
131. Cocco G, Chu D. C. C, & Pandolfi S. Colchicine in clinical medicine. A guide for internists. Eur. J. Internal Med. 21, 503-508 (2010).
132. Lazaar A. L, et al. SB 656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. Br. J. Clin. Pharmacol. 72, 282-293 (2011).
133. Moss R. B, et al. Safety and early treatment effects of the CXCR2 antagonist SB 656933 in patients with cystic fibrosis. J. Cyst. Fibros. 12, 241-248 (2013).
134. Horuk R. Chemokine receptor antagonists: overcoming developmental hurdles. Nat. Rev. Drug Discov. 8, 23-33 (2009).
135. Dalli J, et al. Resolvin D3 and aspirin-Triggered resolvin D3 are potent immunoresolvents. Chem. Biol. 20, 188-201 (2013).
136. Eickmeier O, et al. Aspirin-Triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol. 6, 256-266 (2013).
137. Schwab J. M, Chiang N, Arita M, & Serhan C. N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 447, 869-874 (2007).
138. Dovi J. V, He L. K. K, & DiPietro L. A. Accelerated wound closure in neutrophil-depleted mice. J. Leukoc. Biol. 73, 448-455 (2003).
139. Li L, Yan B, Shi Y. Q. Q, Zhang W. Q. Q, & Wen Z. L. L. Live imaging reveals differing roles of macrophages and neutrophils during zebrafish tail fin regeneration. J. Biol. Chem. 287, 25353-25360 (2012).
140. Paoliello-Paschoalato A. B, et al. Isolation of healthy individuals' and rheumatoid arthritis patients' peripheral blood neutrophils by the gelatin and Ficoll- Hypaque methods: comparative efficiency and impact on the neutrophil oxidative metabolism and Fcγ receptor expression. J. Immunol. Methods. 412, 70-77 (2014).
141. Collins S. J, Ruscetti F. W, Gallagher R. E, & Gallo R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl Acad. Sci. USA. 75, 2458-2462 (1978).
142. Tucker K. A, Lilly M. B, Heck L, & Rado T. A. Characterization of a new human diploid myeloid leukemia cell line (PLB 985) with granulocytic and monocytic differentiating capacity. Blood. 70, 372-378 (1987).
143. Berthier E, Surfus J, Verbsky J, Huttenlocher A, & Beebe D. An arrayed high-content chemotaxis assay for patient diagnosis. Integr. Biol. 2, 630-638 (2010).
144. Montanez-Sauri S. I, Beebe D. J, & Sung K. E. Microscale screening systems for 3D cellular microenvironments: platforms, advances, and challenges. Cell. Mol. Life Sci. 72, 237-249 (2015).
145. Boneschansker L, Yan J, Wong E, Briscoe D. M, & Irimia D. Microfluidic platform for the quantitative analysis of leukocyte migration signatures. Nat. Commun. 5, 4787 (2014).
146. Yamahashi Y, et al. Integrin associated proteins differentially regulate neutrophil polarity and directed migration in 2D and 3D. Biomed. Microdevices. 17, 100 (2015).
147. Mantopoulos D, Cruzat A, & Hamrah P. In vivo imaging of corneal inflammation: new tools for clinical practice and research. Semin. Ophthalmol. 25, 178-185 (2010).
148. Ley K, et al. Sequential contribution of L- And P selectin to leukocyte rolling in vivo. J. Exp. Med. 181, 669-675 (1995).
149. Zarbock A, Lowell C. A, & Ley K. Spleen tyrosine kinase Syk is necessary for E selectin-induced αLβ2 integrin-mediated rolling on intercellular adhesion molecule 1. Immunity. 26, 773-783 (2007).
150. Emre Y, Jemelin S, & Imhof B. A. Imaging neutrophils and monocytes in mesenteric veins by intravital microscopy on anaesthetized mice in real time. J. Vis. Exp. 105 http://dx.doi.org/10.3791/53314 (2015).
151. Jenne C. N, Wong C. H, Petri B, & Kubes P. The use of spinning-disk confocal microscopy for the intravital analysis of platelet dynamics in response to systemic and local inflammation. PLoS ONE 6, e25109 (2011).
152. Looney M. R, et al. Stabilized imaging of immune surveillance in the mouse lung. Nat. Methods. 8, 91-96 (2011).
153. Wong J, et al. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J. Clin. Invest. 99, 2782-2790 (1997).
154. Slaba I, et al. Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice. Hepathology. 62, 1593-1605 (2015).
155. Walters K. B, Green J. M, Surfus J. C, Yoo S. K, & Huttenlocher A. Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome. Blood. 116, 2803-2811 (2010).
156. Deng Q, Yoo S. K, Cavnar P. J, Green J. M, & Huttenlocher A. Dual roles for Rac2 in neutrophil motility and active retention in zebrafish hematopoietic tissue. Dev. Cell. 21, 735-745 (2011).
157. Henry K. M, Loynes C. A, Whyte M. K, & Renshaw S. A. Zebrafish as a model for the study of neutrophil biology. J. Leukoc. Biol. 94, 633-642 (2013).
158. Lieschke G. J, Oates A. C, Crowhurst M. O, Ward A. C, & Layton J. E. Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood. 98, 3087-3096 (2001).
159. Harvie E. A, & Huttenlocher A. Neutrophils in host defense: new insights from zebrafish. J. Leukoc. Biol. 98, 523-537 (2015).
160. Berthier E, et al. Low-volume toolbox for the discovery of immunosuppressive fungal secondary metabolites. PLoS Pathog. 9, e1003289 (2013).
161. Graziano B. R, & Weiner O. D. Self-organization of protrusions and polarity during eukaryotic chemotaxis. Curr. Opin. Cell Biol. 30, 60-67 (2014).
162. Deng Q, & Huttenlocher A. Leukocyte migration from a fish eye's view. J. Cell Sci. 125, 3949-3956 (2012).
163. Baker M. J, Pan D, & Welch H. C. Small GTPases and their guanine-nucleotide exchange factors and GTPase-Activating proteins in neutrophil recruitment. Curr. Opin. Hematol. 23, 44-54 (2016).
164. Mócsai A, Walzog B, & Lowell C. A. Intracellular signalling during neutrophil recruitment. Cardiovasc. Res. 107, 373-385 (2015).
165. Weiner O. D. Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass. Curr. Opin. Cell Biol. 14, 196-202 (2002).
166. Kölsch V, Charest P. G, & Firtel R. A. The regulation of cell motility and chemotaxis by phospholipid signaling. J. Cell Sci. 121, 551-559 (2008).
167. Afonso P. V, & Parent C. A. PI3K and chemotaxis: a priming issue? Sci. Signal. 4, pe22 (2011).
168. Kunisaki Y, et al. DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis. J. Cell Biol. 174, 647-652 (2006).
169. Welch H. C, et al. P-Rex1, a PtdIns(3,4,5)P3- And Gβγ- regulated guanine-nucleotide exchange factor for Rac. Cell 108 809-821 (2002).
170. Heit B, Tavener S, Raharjo E, & Kubes P. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159, 91-102 (2002).
171. Raghuwanshi S. K, et al. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. J. Immunol. 189, 2824-2832 (2012).
172. Yoo S. K, et al. Differential regulation of protrusion and polarity by PI3K during neutrophil motility in live zebrafish. Dev. Cell. 18, 226-236 (2010).
173. Beerman R. W, et al. Direct in vivo manipulation and imaging of calcium transients in neutrophils identify a critical role for leading-edge calcium flux. Cell Rep. 13, 2107-2117 (2015).
174. Hu N, et al. Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177. PLoS ONE 9, e99671 (2014).
175. Welin A, et al. The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitro. PLoS ONE 8, e69575 (2013).
176. Fridlender Z. G, et al. Polarization of tumor-Associated neutrophil phenotype by TGF-β: N1 versus N2 TAN. Cancer Cell. 16, 183-194 (2009).
177. Hartl D, et al. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J. Immunol. 181, 8053-8067 (2008).
178. Tirouvanziam R, et al. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc. Natl Acad. Sci. USA. 105, 4335-4339 (2008).
179. Bauer S, et al. Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils. J. Leukoc. Biol. 81, 458-464 (2007).
180. Carmona-Rivera C, & Kaplan M. J. Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin. Immunopathol. 35, 455-463 (2013).
181. Drifte G, Dunn-Siegrist I, Tissières P, & Pugin J. Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome. Crit. Care Med. 41, 820-832 (2013).
182. Bowers N. L, et al. Immune suppression by neutrophils in HIV 1 infection: role of PD L1/PD 1 pathway. PLoS Pathog. 10, e1003993 (2014).
183. Cloke T, et al. Phenotypic alteration of neutrophils in the blood of HIV seropositive patients. PLoS ONE 8, e72034 (2013).
184. Matsushima H, et al. Neutrophil differentiation into a unique hybrid population exhibiting dual phenotype and functionality of neutrophils and dendritic cells. Blood. 121, 1677-1689 (2013).
185. Nair P, et al. Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin. Exp. Allergy. 42, 1097-1103 (2012).
186. Opfermann P, et al. A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on pump coronary artery bypass graft surgery. Clin. Exp. Immunol. 180, 131-142 (2015).
187. Bertini R, et al. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor. Br. J. Pharmacol. 165, 436-454 (2012).
188. Leaker B. R, Barnes P. J, & O'Connor B. Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist. Respiratory Res. 14, 137 (2013).
189. Miller B. E, et al. The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) -A selective CXCR2 antagonist -in healthy adult subjects. BMC Pharmacol. Toxicol. 16, 18 (2015).
190. Jurcevic S, et al. The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions. Br. J. Clin. Pharmacol. 80, 1324-1336 (2015).
191. Nicholls D. J, et al. Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist. J. Pharmacol. Exp. Ther. 353, 340-350 (2015).
192. US National Library of Medicine. ClinicalTrials.gov [online], https: //clinicaltrials.gov/ct2/show/.NCT01972776 (2016).
193. US National Library of Medicine. ClinicalTrials.gov [online], https: //www.clinicaltrialsregister.eu/ctr-search/trial/2012-005615-92/DE (2015).